Certainly, here's a more measuredThe consistent message from Daws and Warriner emphasizes that the model developed over the past six months is leading to significant new discoveries, notably at the surface level.
This model will be pivotal for the forthcoming drill program, which I believe will mark the beginning of Estrella Resources' market capitalization expanding from tens of millions (currently 33 million) to hundreds of millions.Monitor closely for the drill program announcement, which i expect to formulated and announced around January.Recent polarization imaging has indicated anomalies to a depth of 50 meters, suggesting significant near-surface potential.
If this is validated by core sampling assays, the implications will be profound.
A successful drill program will propel the stock to stupid money valuations, making this program a critical factor to watch for those in early on Estrella.
- Forums
- ASX - By Stock
- ESR
- Ann: Induced Polarisation Trial Successful
ESR
estrella resources limited
Add to My Watchlist
2.04%
!
4.8¢

Ann: Induced Polarisation Trial Successful, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $98.49M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.8¢ | $37.21K | 760.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 313538 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 119606 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 313538 | 0.048 |
6 | 430601 | 0.047 |
5 | 1149792 | 0.046 |
7 | 3435926 | 0.045 |
3 | 1096388 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 119606 | 1 |
0.050 | 221544 | 4 |
0.051 | 45000 | 1 |
0.052 | 305000 | 3 |
0.053 | 350000 | 2 |
Last trade - 15.32pm 25/06/2025 (20 minute delay) ? |
Featured News
ESR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online